Vui Heng Chong1,2,3, Lydiana Kadir4, Zakaria Kamis4, Norhayati Kassim4, Muhammad Abdul Mabood Khalil5, Jackson Tan3,5, Elvynna Leong6, Sok King Ong7, Chee Fui Chong5. 1. Department of Medicine, RIPAS Hospital, Brunei Darussalam. 2. Department of Medicine, PMMPHAMB Hospital, Brunei Darussalam. 3. PAPRSB Institute of Health Science, Universiti Brunei Darussalam, Brunei Darussalam. 4. Health Promotion Centre, Ministry of Health, Brunei Darussalam. 5. RIPAS Hospital, Bandar Seri Begawan, Brunei Darussalam. 6. Universiti Brunei Darussalam, Brunei Darussalam. 7. Public Health Services, Ministry of Health Brunei Darussalam.
Abstract
INTRODUCTION: Colorectal cancers (CRC) continues to increase worldwide and is associated with significant morbidity and mortality. CRC can be prevented through early detection using several modalities. However, like any screening program participation remains suboptimal. This study assessed the factors associated with participation in a stool based CRC screening that was carried out as part of an Integrated Health Screening Survey for civil servants. MATERIALS AND METHODS: Civil servants who participated in a health survey (N=10,756, mean age 48.08 ± 5.26 years old) were studied. Demographic factors (gender, age groups, marital status, employment status, body mass index [BMI] categories, smoking status, personal and family history of cancers) were analyzed to assess for features associated with willingness to participate in this fecal immunohistochemistry test (FIT) screening for CRC. Comorbid conditions studied were cardiac disease, diabetes mellitus, dyslipidemia, hypertension and stroke. Multivariate analysis was performed to evaluate variables associated with participation in CRC screening programme. RESULTS: Of the invited 10,756 participants, 7,360 returned a stool specimen giving a participation rate of 68.4%. Those who participated were significantly older (60 years [77.8%], p0.05). Multivariate analyses showed that older age (45-49, 50-54, 55-59 and >60) and employment status (professional) remained significant factors associated with participation in a stool based CRC screening. CONCLUSIONS: Our study showed that older age and professional employment status were significantly associated with willingness to participate in a stool based CRC screening.
INTRODUCTION:Colorectal cancers (CRC) continues to increase worldwide and is associated with significant morbidity and mortality. CRC can be prevented through early detection using several modalities. However, like any screening program participation remains suboptimal. This study assessed the factors associated with participation in a stool based CRC screening that was carried out as part of an Integrated Health Screening Survey for civil servants. MATERIALS AND METHODS: Civil servants who participated in a health survey (N=10,756, mean age 48.08 ± 5.26 years old) were studied. Demographic factors (gender, age groups, marital status, employment status, body mass index [BMI] categories, smoking status, personal and family history of cancers) were analyzed to assess for features associated with willingness to participate in this fecal immunohistochemistry test (FIT) screening for CRC. Comorbid conditions studied were cardiac disease, diabetes mellitus, dyslipidemia, hypertension and stroke. Multivariate analysis was performed to evaluate variables associated with participation in CRC screening programme. RESULTS: Of the invited 10,756 participants, 7,360 returned a stool specimen giving a participation rate of 68.4%. Those who participated were significantly older (60 years [77.8%], p0.05). Multivariate analyses showed that older age (45-49, 50-54, 55-59 and >60) and employment status (professional) remained significant factors associated with participation in a stool based CRC screening. CONCLUSIONS: Our study showed that older age and professional employment status were significantly associated with willingness to participate in a stool based CRC screening.
Authors: William E Barlow; Elisabeth F Beaber; Berta M Geller; Aruna Kamineni; Yingye Zheng; Jennifer S Haas; Chun R Chao; Carolyn M Rutter; Ann G Zauber; Brian L Sprague; Ethan A Halm; Donald L Weaver; Jessica Chubak; V Paul Doria-Rose; Sarah Kobrin; Tracy Onega; Virginia P Quinn; Marilyn M Schapira; Anna N A Tosteson; Douglas A Corley; Celette Sugg Skinner; Mitchell D Schnall; Katrina Armstrong; Cosette M Wheeler; Michael J Silverberg; Bijal A Balasubramanian; Chyke A Doubeni; Dale McLerran; Jasmin A Tiro Journal: J Natl Cancer Inst Date: 2020-03-01 Impact factor: 13.506
Authors: Ulrik Deding; Anna Sharon Henig; Peter Hindersson; Christian Torp-Pedersen; Henrik Bøggild Journal: Eur J Public Health Date: 2019-12-01 Impact factor: 3.367
Authors: Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman Journal: CA Cancer J Clin Date: 2011-02-04 Impact factor: 508.702
Authors: Natalie Dodd; Mariko Carey; Elise Mansfield; Christopher Oldmeadow; Tiffany-Jane Evans Journal: Aust N Z J Public Health Date: 2019-07-03 Impact factor: 2.939
Authors: L Hol; M E van Leerdam; M van Ballegooijen; A J van Vuuren; H van Dekken; J C I Y Reijerink; A C M van der Togt; J D F Habbema; E J Kuipers Journal: Gut Date: 2010-01 Impact factor: 23.059
Authors: J J Y Sung; S C Ng; F K L Chan; H M Chiu; H S Kim; T Matsuda; S S M Ng; J Y W Lau; S Zheng; S Adler; N Reddy; K G Yeoh; K K F Tsoi; J Y L Ching; E J Kuipers; L Rabeneck; G P Young; R J Steele; D Lieberman; K L Goh Journal: Gut Date: 2014-03-19 Impact factor: 23.059